	当期純利益		日付
Acadia Pharmaceuticals	USD 273.57M	201.79M	2025-12
Adma Biologics	USD 49.38M	12.95M	2025-12
ALKERMES	USD 49.34M	33.42M	2025-12
Alterity Therapeutics Limited	AUD -5.77M	2.26M	2023-06
AstraZeneca	USD 2.33B	207M	2025-12
BioCryst Pharmaceuticals	USD 245.84M	232.95M	2025-12
Bristol-Myers Squibb	USD 1.09B	1.11B	2025-12
Cipla	INR 6.76B	6.75B	2025-12
Clal Biotechnology	ILS -6.17M	15.56M	2022-12
Compugen	USD 56.84M	63.82M	2025-12
CSL	USD 401M	96.5M	2025-12
Eli Lilly	USD 6.64B	1.05B	2025-12
Esperion Therapeutics	USD 61.83M	93.16M	2025-12
GlaxoSmithKline	GBP 636M	1.38B	2025-12
Grifols	EUR 114.37M	34.03M	2025-12
Halozyme Therapeutics	USD -141.59M	316.82M	2025-12
Ionis Pharmaceuticals	USD -229M	100.39M	2025-12
J&J	USD 5.12B	36M	2025-12
Merck	USD 2.96B	2.82B	2025-12
Minerva Neurosciences	USD 1.44M	21.07M	2024-12
Neurocrine Biosciences	USD 209.5M	102M	2025-09
Novartis	USD 2.41B	1.52B	2025-12
Novavax	USD 17.53M	219.91M	2025-12
Pfizer	USD -1.65B	5.19B	2025-12
Roche Holding	CHF 5.47B	1.76B	2025-12
Sanofi	EUR -801M	3.6B	2025-12
Takeda	JPY 103.64B	115.44B	2025-12
Vanda Pharmaceuticals	USD -18.9M	13.58M	2024-12